about
Osteoprotegerin as a marker of atherosclerosis: a systematic update.Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAsThe Western Denmark Cardiac Computed Tomography Registry: a review and validation study.Abdominal ultrasound-scanning versus non-contrast computed tomography as screening method for abdominal aortic aneurysm - a validation study from the randomized DANCAVAS studyClinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker.Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes.Association between high-sensitive troponin I and coronary artery calcification in a Danish general population.The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy.Association between aortic valve calcification measured on non-contrast computed tomography and aortic valve stenosis in the general population.Prognostic Impact of Myocardial Injury Related to Various Cardiac and Noncardiac Conditions.Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus.Clinical impact of 18F-FDG-PET/CT in the extra cardiac work-up of patients with infective endocarditis.The value of FDG-PET/CT in the diagnostic work-up of extra cardiac infectious manifestations in infectious endocarditis.Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?Optimal cut-off value for cardiac troponin I in ruling out Type 5 myocardial infarction.Computed tomography scan based prediction of the vulnerable carotid plaque.Flow cytometric investigation of immune-response-related surface molecules on human colorectal cancers.Changes in left ventricular filling patterns after repeated injection of autologous bone marrow cells in heart failure patients.Population screening for coronary artery calcification does not increase mental distress and the use of psychoactive medication.Patients With Suspected Coronary Artery Disease Referred for Examinations in the Era of Coronary Computed Tomography Angiography.Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the Danish stem cell study--congestive heart failure trial (DanCell-CHF).Prevalence of coronary artery calcification in a non-specific chest pain population in emergency and cardiology departments compared with the background population: a prospective cohort study in Southern Denmark with 12-month follow-up of cardiac enPlasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients.Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects.Delayed ¹⁸F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study.Gender and age effects on risk factor-based prediction of coronary artery calcium in symptomatic patients: A Euro-CCAD study.The coronary calcium score is a more accurate predictor of significant coronary stenosis than conventional risk factors in symptomatic patients: Euro-CCAD study.Coronary computed tomography angiography - tolerability of β-blockers and contrast media, and temporal changes in radiation dose.Delayed sodium 18F-fluoride PET/CT imaging does not improve quantification of vascular calcification metabolism: results from the CAMONA study.Non-invasive assessments reveal that more than half of randomly selected middle-aged individuals have evidence of subclinical atherosclerosis: a DanRisk substudy.Patients' views of cardiac computed tomography angiography compared with conventional coronary angiography.Diagnostic value of cardiac 64-slice computed tomography: importance of coronary calcium.Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculinEffects of menaquinone-7 supplementation in patients with aortic valve calcification: study protocol for a randomised controlled trialDiagnostic accuracies of screening for atrial fibrillation by cardiac nurses versus radiographersCharacterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancerPrognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cellsImmunohistochemical characterisation of the local immune response in azoxymethane-induced colon tumours in the BDIX inbred rat strainChanges in medical treatment six months after risk stratification with HeartScore and coronary artery calcification scanning of healthy middle-aged subjectsDiscrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study
P50
Q34234163-9576093C-5CA3-4315-BCEF-86934B13BE05Q34785177-E3B7FEC0-699E-4360-9211-C19DDCEBFFA0Q35049366-A459528C-9E19-4790-B284-3FEF62F7BA63Q36279272-6212536B-E7D1-44C9-B629-720E0CDEAA31Q36367463-AB7F3B11-B6EA-4675-BB5C-238C0C142D7FQ36604574-0795E0DD-5307-43BA-B991-9D6398A112B7Q38927001-1AADC20E-59A4-432F-9348-C5CB499C8340Q40008061-179D2095-60CE-4685-92E8-04D850983567Q40725607-F4759FB4-B478-431E-A662-2DADB9BDB11AQ40979473-A69994A9-4F24-4583-A354-36C13292E7BBQ41079953-7FBAED98-B882-48EE-B1C0-415928F17972Q42220247-BA52B7C1-6391-41BA-BD7E-A3603655000CQ42262136-EE8476BB-254B-47C2-B285-DF0B4B909823Q42676286-D49D1515-A35D-4836-82E7-C7882615812AQ44799286-008AE137-63DD-4477-8308-54F7625DE438Q47141462-B38AE716-B6DA-4C3C-BDA3-F500AC606738Q47916084-7DE07D27-93FC-41AE-ACF8-957E3DAEA22AQ48270981-790DD04D-E27E-410B-9F65-8226B8A020D5Q48730508-31D9FF90-B7F1-4150-ACFE-D8A8050168B9Q50547473-EDD8C8DD-82CA-4C6A-B2E7-9D4A31C3803EQ50547745-1D3BB6E5-7F5F-4C6E-BF54-C29E37966C20Q50578083-52A63B95-1994-461A-8976-95D3927F19E3Q50648308-F46FC45F-9FB2-4BA5-8D40-B649498B869DQ51037892-6F330079-6C31-4490-BAAC-0F7A79F4E24AQ51101683-B5816BFE-A42B-4CDC-A8B2-A93CBF1FFF16Q51214131-02C6B8C2-D7B4-48D0-AA32-E8318F53952FQ51555196-7CD7A4A5-FE93-4FFC-992C-B6207E981EB1Q53057193-56DDC72B-CB5F-425E-AA21-9CDA6659B511Q53086650-5E384393-771F-4626-9F46-8818EA5F00B2Q53153699-9F474F0D-389C-4BBB-B2ED-D16CFB3FFC77Q53235891-E701AEDD-1280-4E1B-BE3E-BD37F05E648FQ53365473-62EE75CB-2778-45B7-88A0-FEF66DD66181Q57279131-2A6236E6-3E2B-4E3E-99B9-316E150238DDQ58713157-0057E4D8-DD3C-4AA5-9BDF-DC891E604C30Q64083427-955F5DD9-E2B2-465A-A79C-1E3D5AE381FCQ73038086-0538C226-2F24-47B2-8F64-15DE2954FDCEQ73271114-D0032DAD-6E06-4566-B3E6-5A52B6533D5CQ81151459-33F4F439-54C0-4452-84B6-6446D5F4F34FQ82151502-B5109696-32C3-4DE7-9726-28F808870A6DQ83984234-4425D7D8-8A43-49BD-94C9-DA788CF7A9E9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Axel Cosmus Pyndt Diederichsen
@ast
Axel Cosmus Pyndt Diederichsen
@en
Axel Cosmus Pyndt Diederichsen
@es
Axel Cosmus Pyndt Diederichsen
@nl
type
label
Axel Cosmus Pyndt Diederichsen
@ast
Axel Cosmus Pyndt Diederichsen
@en
Axel Cosmus Pyndt Diederichsen
@es
Axel Cosmus Pyndt Diederichsen
@nl
prefLabel
Axel Cosmus Pyndt Diederichsen
@ast
Axel Cosmus Pyndt Diederichsen
@en
Axel Cosmus Pyndt Diederichsen
@es
Axel Cosmus Pyndt Diederichsen
@nl
P106
P1153
36853035600
P31
P496
0000-0002-1285-4826